Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Deferred tax assets
Net operating loss carryforward	$ 382,887	$ 407,235
Research and development credits	74,496	73,352
Research and development expenditure capitalization	148,870	201,814
Basis difference in investments	416	138
Sales tax accrual	139	67
Share-based compensation	5,668	5,926
Acquired intangibles	111,750	91,943
Accrued liabilities	11,847	15,141
Gross deferred tax assets	736,073	795,616
Valuation allowance	(607,853)	(644,379)
Total deferred tax assets	128,220	151,237
Deferred tax liabilities
Deferred sales commissions	(85,101)	(104,236)
Lease right of use assets	(4,247)	(6,948)
Property and equipment	(36,802)	(35,837)
Net deferred tax assets	$ 2,070	$ 4,216